Venn Life Sciences (LON:VENN) Stock Passes Below Two Hundred Day Moving Average – Here’s What Happened

Venn Life Sciences Holdings PLC (LON:VENN) shares crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 6.85 ($0.09) and traded as low as GBX 6.70 ($0.09). Venn Life Sciences shares last traded at GBX 6.85 ($0.09), with a volume of 1,027,544 shares traded.

Venn Life Sciences Price Performance

The stock has a 50 day moving average price of GBX 6.85 and a two-hundred day moving average price of GBX 6.85. The company has a debt-to-equity ratio of 35.83, a current ratio of 2.30 and a quick ratio of 1.48. The firm has a market capitalization of £4.89 million and a price-to-earnings ratio of -2.14.

Venn Life Sciences Company Profile

Venn Life Sciences Holdings Plc, a clinical research organization, provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device companies in the United Kingdom, Ireland, France, the Netherlands, Germany, and Singapore. The company offers drug development planning and strategy services, including clinical feasibility assessment, project management, and in-licensing and technical due diligence; and early drug development services, such as drug candidate selection, CMC, non-clinical/pre-clinical development, clinical pharmacology, pharmacokinetics, and pharmacometrics and PK-PD modelling.